Question for you: as a TERA shareholder, did you really gain solid intellectual property from Cray? Was it worth it, at the low-level? Is there a solid mind share with SGI now? Are you thinking of a broader market strategy than before? Thanks!
It's entirely obvious that the very first commericial application of the technology will be a Viagra-like product to open up penile cells in a rather artifically time-extended state. Combined with SOMA, the results should be excellent.
Question for you: as a TERA shareholder, did you really gain solid intellectual property from Cray? Was it worth it, at the low-level? Is there a solid mind share with SGI now? Are you thinking of a broader market strategy than before? Thanks!
wow, dont let your digressions circumscribe you...
Im rather hungry ...
It's entirely obvious that the very first commericial application of the technology will be a Viagra-like product to open up penile cells in a rather artifically time-extended state. Combined with SOMA, the results should be excellent.